Distribution of therapeutic areas for approved biopharmaceutical Investigational New Drug (IND) applications in China in 2024

Statista60

Drug products sales distribution in selected countries in 2022, by therapeutic class

Statista40

Distribution of new medicines in the pre-registration phase of the R&D pipeline worldwide in 2023, by therapeutic class

Statista20

Therapeutic areas for approved biopharmaceutical NDA in China 2024

资源简介：